BLCO (Bausch & Lomb) Book Value per Share: $17.90 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BLCO Bausch & Lomb Corp BLCO
77 GF Score
Price $16.81
GF Value $18.66
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Bausch & Lomb Book Value per Share?

Bausch & Lomb BLCO +3.26% 77 Book Value per Share is $17.90 as of Mar. 2026. GuruFocus rates BLCO with a GF Score™ of 77/100 and a GF Value™ of $18.66 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Bausch & Lomb's book value per share for the quarter that ended in Mar. 2026 was $17.90.

During the past 12 months, Bausch & Lomb's average Book Value Per Share Growth Rate was -5.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -2.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Bausch & Lomb was -2.70% per year. The lowest was -10.30% per year. And the median was -9.25% per year.

Bausch & Lomb's current price is $16.81. Its book value per share for the quarter that ended in Mar. 2026 was $17.90. Hence, today's PB Ratio of Bausch & Lomb is 0.94.

During the past 8 years, the highest P/B Ratio of Bausch & Lomb was 1.13. The lowest was 0.60. And the median was 0.86.

Warning Sign:

Bausch & Lomb Corp stock PB Ratio (=0.93) is close to 1-year high of 1.


Bausch & Lomb  (NYSE:BLCO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Bausch & Lomb Book Value per Share Related Terms


Bausch & Lomb Book Value per Share Historical Data

* Premium members only.

The historical data trend for Bausch & Lomb's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch & Lomb Book Value per Share Chart

Bausch & Lomb Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Book Value per Share
Get a 7-Day Free Trial 26.65 20.09 19.52 18.37 18.20

Bausch & Lomb Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.00 18.20 18.16 18.20 17.90

BLCO vs ISRG, BDX, MDLN: Book Value per Share Comparison

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch & Lomb PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's PB Ratio distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's PB Ratio falls into.


BLCO
77GF Score
Bausch & Lomb Corp BLCO
Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch & Lomb Book Value per Share Calculation

Bausch & Lomb's Book Value Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6,448-0)/354
=18.20

Bausch & Lomb's Book Value Per Share for the quarter that ended in Mar. 2026 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6,379-0)/356
=17.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $17.90 mean?
Bausch & Lomb (BLCO) has a Book Value per Share of $17.90 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Bausch & Lomb and its competitors.
Is Bausch & Lomb's Book Value per Share too high?
Bausch & Lomb's current Book Value per Share is $17.90. Overall, Bausch & Lomb has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bausch & Lomb's Book Value per Share compare to ISRG and BDX?
Bausch & Lomb's Book Value per Share of $17.90 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Devices & Instruments company?
A good Book Value per Share depends on the Medical Devices & Instruments industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Bausch & Lomb and its competitors. Bausch & Lomb's current Book Value per Share is $17.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch & Lomb stock overvalued right now?
Based on GuruFocus' analysis, Bausch & Lomb (BLCO) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.66, compared to a current price of $16.81 — trading 9.9% below its estimated fair value. The current Book Value per Share is $17.90. Bausch & Lomb's overall GF Score™ is 77/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Bausch & Lomb (BLCO), the current Book Value per Share is $17.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch & Lomb (BLCO) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch & Lomb stock appears to be undervalued. The current stock price of $16.81 is trading 9.9% below its estimated GF Value™ of $18.66. GuruFocus considers Bausch & Lomb to be Modestly Undervalued.

Key valuation signals for BLCO:

  • Book Value per Share: $17.90
  • GF Value™: $18.66 vs. price of $16.81 (9.9% below fair value)
  • GF Score™: 77/100 with 9 warning signs

No single metric tells the full story. See the BLCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch & Lomb Business Description

Other Exchanges S2L:GermanyBLCO:Canada
Address 520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
77GF Score

Get the complete analysis for BLCO

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.81
Price
$18.66
GF Value